Combined Screening with NIPT (Delfia).

Combined Screening with NIPT (Delfia)

Combined Screening with NIPT (Delfia) is an advanced prenatal screening package designed to assess the risk of common chromosomal abnormalities in the baby during early pregnancy. It combines the accuracy of NIPT (Non-Invasive Prenatal Testing) with important maternal serum markers and ultrasound findings for a more comprehensive evaluation.

What This Test Screens For

• Down Syndrome (Trisomy 21)
• Edwards Syndrome (Trisomy 18)
• Patau Syndrome (Trisomy 13)
• Sex chromosome abnormalities
• Additional chromosomal risk assessment (depending on panel selection)

What Is Included

• Maternal blood screening using DELFIA technology
• NIPT analysis from maternal blood sample
• Combined first trimester risk assessment
• Correlation with NT scan findings (if available)

Why This Test Is Important

• Non-invasive and safe for both mother and baby
• High sensitivity and accuracy
• Helps identify chromosomal risks early in pregnancy
• Supports informed medical guidance and pregnancy management
• Reduces unnecessary invasive procedures in many cases

Recommended For

• Pregnant women in the first trimester
• Advanced maternal age pregnancies
• Previous history of chromosomal abnormalities
• High-risk or IVF pregnancies
• Anyone seeking advanced prenatal reassurance

Sample Required

• Maternal blood sample

Preparation

• No fasting required

Reporting Time

• Usually within 7–10 working days

Note

This is a screening test, not a diagnostic confirmation. Positive or high-risk results may require further clinical evaluation or confirmatory testing as advised by your doctor.